GAIA BioMedicine Inc., founded in 2015 and headquartered in Fukuoka Prefecture, Japan, is focused on the development of regenerative medicine products, particularly in the field of biopharmaceuticals. The company specializes in cancer immuno-cell therapy, leveraging advanced technology and intellectual property to create innovative cell therapies and immunotherapies. GAIA BioMedicine aims to empower patients to combat intractable malignancies by harnessing the capabilities of genes and the immune system, thereby addressing significant medical challenges associated with difficult-to-treat cancers.
GAIA BioMedicine Inc., founded in 2015 and headquartered in Fukuoka Prefecture, Japan, is focused on the development of regenerative medicine products, particularly in the field of biopharmaceuticals. The company specializes in cancer immuno-cell therapy, leveraging advanced technology and intellectual property to create innovative cell therapies and immunotherapies. GAIA BioMedicine aims to empower patients to combat intractable malignancies by harnessing the capabilities of genes and the immune system, thereby addressing significant medical challenges associated with difficult-to-treat cancers.
SK Fine Co., Ltd. is a Japanese company established in 2018, located in Kusatsu City. It specializes in manufacturing and marketing ceramic molded parts and has pioneered the development of 3D printers specifically for ceramics, becoming the first in Japan to launch such a product. In addition to its innovative printing technology, SK Fine also engages in outsourced development and joint development projects, leveraging its expertise in 3D ceramic printing to create tailored molding processes for ceramic components.
Developer of wireless embedded brain-computer interface system designed to read brain activity. The company offers a wireless implantable BCI system to read brain activity using an implanted device and Artificial intelligence and operate the device by thinking, enabling ALS patients to improve communication and QOL.
JimEd Limited is a private equity firm focused on providing funding for rapidly growing companies, specifically seeking investments between £20 million and £250 million. The firm is committed to supporting and developing innovative ideas that have the potential to create significant positive impact. JimEd Limited specializes in several key sectors, including Climate Innovations, Technology, Engineering, Health and Wellness, and Transport. Through its targeted investment strategy, the firm aims to foster advancements in these critical areas, contributing to both economic growth and societal betterment.
Immunosens Co. Ltd. is a Japanese company founded in 2018 that specializes in the research, development, manufacturing, and sale of bioanalytical instruments. The company focuses on creating electrochemical measurement devices designed to evaluate biomarkers, including genes, proteins, and cell signals through electrode reactions. By utilizing disposable printable electrodes in its sensors, Immunosens provides healthcare professionals with precise analysis and measurements, which are crucial for accurate diagnosis and food safety inspections. In addition to its product offerings, the company also provides healthcare consulting services, further supporting its commitment to enhancing diagnostic capabilities and safety in health-related fields.
Developer of digital conversion and analysis platform designed to allow not only humans but also robots and AI to understand the real world. The company's digital twin platform promotes the smartening of modern society and industry, creating a human-centered comfortable environment, enabling clients to solve social issues by utilizing the advanced research results cultivated in academics.
Aipore Inc. is a technology company based in Shibuya-ku, Tokyo, Japan, specializing in the development of nanopore sensors that leverage semiconductor microfabrication technology. Founded in 2018, the company focuses on creating IoT-based sensors capable of measuring and analyzing changes in ion current to identify fine particles, including nanoparticles and viruses, with high accuracy. Aipore's innovative technology integrates various advancements such as silicon MEMS, flow path surface control, and low noise amplification circuits, along with artificial intelligence to enhance the analysis of transient ion current changes. These sensors have diverse industrial applications, including microorganism identification, laboratory testing, cancer detection, blood diagnostics, livestock inspection, and environmental evaluations, enabling precise measurement of microparticles across different sectors.
COTOBADESIGN, Inc. specializes in the development and delivery of dialogue artificial intelligence (AI) content. Established in 2017 and headquartered in Tokyo, Japan, the company offers innovative tools aimed at enhancing productivity in various sectors, including elderly and nursing care, business automation, and entertainment. Additionally, COTOBADESIGN provides a platform that supports the development of dialogue AI content, catering to the growing demand for automated communication solutions across different markets.
Periotherapia is a Drug discovery business with triple negative breast cancer as the first indication. Periotherapia aims to selectively inhibit only ASV that is involved in pathogenesis without inhibiting physiological ASV in chronic diseases such as cancer, heart failure, arteriosclerosis, renal failure, and diabetic retinopathy. is.
GlyTech, Inc. specializes in the manufacture of human type N-glycans and glycosylation technologies, as well as glycopeptide and glycoprotein synthesis. Established in 2012 and based in Kyoto, Japan, the company is dedicated to advancing the production of glycans and chemical glycosylation technologies for the development of innovative biopharmaceuticals and oligonucleotide therapeutics. GlyTech licenses glycosylated peptides and proteins and provides a range of services, including contract research and development, custom synthesis, and contract manufacturing. Additionally, the company engages in research collaborations and supplies standard reagents to support its partners in the pharmaceutical industry.
J-Pharma Co., Ltd., founded in 2005 and based in Yokohama, Japan, specializes in the development of therapeutics and diagnostic agents for cancer treatment. The company focuses on a human-genomic approach, creating novel pharmaceuticals that target specific diseases with selective agents. J-Pharma's research emphasizes the role of cell membrane transporters, which are linked to various diseases, particularly in cancer. The company has identified significant drug transporters within the human body that can enhance the evaluation and optimization of pharmacokinetics for new drug candidates. J-Pharma's product pipeline includes anti-cancer drugs and PET diagnostic agents targeting LAT1, a transporter protein associated with cancer cell growth. Through its innovative drug development and diagnostic methods, J-Pharma aims to improve human health and welfare, particularly for the aging population in industrialized nations.
PGV Co., Ltd. is a Japanese company founded in September 2016 that focuses on the electroencephalograph (EEG) sector. The company aims to empower individuals to engage in self-care by enabling them to measure and understand their brain waves throughout their life cycle. PGV develops devices that utilize EEG technology and artificial intelligence to analyze brain activity, promoting a greater understanding of mental health and well-being. By providing tools for personal brain wave monitoring, PGV seeks to enhance individual self-awareness and foster proactive approaches to mental health management.
Kringle Pharma, Inc. is a biopharmaceutical company focused on the research and development of hepatocyte growth factor (HGF) protein medicines and NK4 molecules. Established in 2001 and headquartered in Japan, the company aims to harness the regenerative properties of HGF for various medical conditions, including acute spinal cord injury, amyotrophic lateral sclerosis (ALS), acute kidney injury, and vocal fold scarring. In addition to HGF, Kringle Pharma develops NK4, which acts as an antagonist to HGF and exhibits anti-cancer properties by inhibiting tumor cell invasion and metastasis. The company's product pipeline includes recombinant human HGF for treating acute renal failure, skin ulcers, and central nervous system disorders, as well as NK4 and NK4 gene therapies for cancer treatment.
Luxna Biotech Co., Ltd. is a Japanese company focused on the development of nucleic acid drugs, utilizing advanced technology to enhance the practical application of these therapies. Founded in 2017 and based in Suita, Japan, the company provides drug discovery support through artificial nucleic acid technology. Luxna Biotech aims to contribute to medical treatment, addressing the needs of patients with various health conditions.
PGV Co., Ltd. is a Japanese company founded in September 2016 that focuses on the electroencephalograph (EEG) sector. The company aims to empower individuals to engage in self-care by enabling them to measure and understand their brain waves throughout their life cycle. PGV develops devices that utilize EEG technology and artificial intelligence to analyze brain activity, promoting a greater understanding of mental health and well-being. By providing tools for personal brain wave monitoring, PGV seeks to enhance individual self-awareness and foster proactive approaches to mental health management.
Remohab Corporation designs remote telemedicine for patients with rehabilitation. The company was founded in 2017 and is based in Suita City, Japan.
mediVR, Inc. specializes in the development and sale of therapeutic medical devices that utilize virtual reality, three-dimensional tracking, and artificial intelligence to assist in exercise rehabilitation. The company's flagship product, mediVR Kagura, is a self-exercise device designed to assess motor function, posture balance, and cognitive abilities necessary for walking. By employing engaging activities and games, the device aims to enhance rehabilitation for patients, particularly those recovering from strokes. MediVR markets its products through a network of distributors and operates from its headquarters in Tokyo, Japan, with an additional office in Osaka. Founded in 2016, the company is focused on improving healthcare systems through innovative technology.
Immunosens Co. Ltd. is a Japanese company founded in 2018 that specializes in the research, development, manufacturing, and sale of bioanalytical instruments. The company focuses on creating electrochemical measurement devices designed to evaluate biomarkers, including genes, proteins, and cell signals through electrode reactions. By utilizing disposable printable electrodes in its sensors, Immunosens provides healthcare professionals with precise analysis and measurements, which are crucial for accurate diagnosis and food safety inspections. In addition to its product offerings, the company also provides healthcare consulting services, further supporting its commitment to enhancing diagnostic capabilities and safety in health-related fields.
Cykinso, Inc. is a Japan-based company established in 2014 that specializes in direct-to-consumer microbiome testing kits. The company offers a home-testing kit designed to assess the state of an individual's intestinal bacteria. Utilizing advanced sequencing technology, the kit analyzes numerous DNA sequences rapidly, providing users with insights into their gut health. This information helps individuals understand the relationship between their intestinal flora and various lifestyle-related and digestive diseases. Through its innovative testing service, Cykinso aims to empower consumers with knowledge about their health conditions based on detailed bacterial flora data.
MiCAN Technologies Inc. is a Kyoto-based company that specializes in producing and supplying blood cell-like products for research purposes, particularly in the field of regenerative medicine. Founded in 2016, the company focuses on the development of new drugs targeting infectious diseases such as malaria and dengue. Its key products include MPV, a red blood-like cell designed for malaria research, and M02, a myeloid lineage cell intended for dengue research. By leveraging pluripotent stem cell technology, MiCAN Technologies aims to advance scientific understanding and treatment of infectious and immune system diseases.
AI Samurai Inc. is a company based in Tokyo, Japan, with a branch office in Osaka, specializing in the development and sales of artificial intelligence technology. Founded in 2015, the company focuses on creating a patent examination platform that leverages AI to evaluate patentability and conduct comprehensive patent searches. This platform aids clients in their research and development efforts by enabling detailed analyses of all patent documents within its database. In addition to its core offerings, AI Samurai also supports patent research and technical investigations, positioning itself as a valuable resource in the field of intellectual property.
Telenoid Healthcare Company Ltd. develops an app (TerenoidTM) for elderly people with dementia. The app acts as a communication between elderly people with dementia and carers and allows the carer to talk to the elderly with dementia by remote control using a camera and a microphone embedded inside the telenoid. It also provides multi-discipline linkage recording application and training services for nursing homes. The company was founded in 2015 and is based in Tokyo, Japan.
ThinkCyte, Inc. develops an artificial intelligence-enabled, image-free visual cell sorting system that sort cells by morphology. It develops and sells equipment (cell separator) that uses cell sorting technology that continuously analyzes and separates cells by automatic control. It integrates optics, genomics, and information science to develop such machines. The company develops an image-based cell sorter using novel optics and machine learning methods. The company was founded in 2016 and is based in Tokyo, Japan with an additional office in San Carlos, California.
Periotherapia is a Drug discovery business with triple negative breast cancer as the first indication. Periotherapia aims to selectively inhibit only ASV that is involved in pathogenesis without inhibiting physiological ASV in chronic diseases such as cancer, heart failure, arteriosclerosis, renal failure, and diabetic retinopathy. is.
PaMeLa Co., Ltd. is a medical device company based in Suita, Japan, founded in 2016. The company focuses on developing innovative technology to measure pain experienced by patients during surgical procedures. By utilizing brain wave analysis, algorithms, and machine learning, PaMeLa aims to create an objective method for quantifying pain. This approach is intended to enhance medical care by providing a scientific basis for pain assessment, thereby improving patient outcomes and treatment strategies.
C4U Co., Ltd. is a Japanese company founded in 2018, specializing in the research and development of genome editing technologies aimed at addressing various intractable diseases. The company utilizes advanced methods such as CRISPR and Cas3 to create a platform that supports drug discovery and facilitates the development of new gene therapies. Beyond the medical field, C4U's innovative technologies are applicable across multiple industries, including agriculture, forestry, livestock, and fisheries, thereby contributing to solutions for a range of social issues. Based in Suita, Japan, C4U is committed to advancing scientific knowledge and practical applications through its cutting-edge genome editing capabilities.
SK Fine Co., Ltd. is a Japanese company established in 2018, located in Kusatsu City. It specializes in manufacturing and marketing ceramic molded parts and has pioneered the development of 3D printers specifically for ceramics, becoming the first in Japan to launch such a product. In addition to its innovative printing technology, SK Fine also engages in outsourced development and joint development projects, leveraging its expertise in 3D ceramic printing to create tailored molding processes for ceramic components.
Aipore Inc. is a technology company based in Shibuya-ku, Tokyo, Japan, specializing in the development of nanopore sensors that leverage semiconductor microfabrication technology. Founded in 2018, the company focuses on creating IoT-based sensors capable of measuring and analyzing changes in ion current to identify fine particles, including nanoparticles and viruses, with high accuracy. Aipore's innovative technology integrates various advancements such as silicon MEMS, flow path surface control, and low noise amplification circuits, along with artificial intelligence to enhance the analysis of transient ion current changes. These sensors have diverse industrial applications, including microorganism identification, laboratory testing, cancer detection, blood diagnostics, livestock inspection, and environmental evaluations, enabling precise measurement of microparticles across different sectors.
COTOBADESIGN, Inc. specializes in the development and delivery of dialogue artificial intelligence (AI) content. Established in 2017 and headquartered in Tokyo, Japan, the company offers innovative tools aimed at enhancing productivity in various sectors, including elderly and nursing care, business automation, and entertainment. Additionally, COTOBADESIGN provides a platform that supports the development of dialogue AI content, catering to the growing demand for automated communication solutions across different markets.
AI Samurai Inc. is a company based in Tokyo, Japan, with a branch office in Osaka, specializing in the development and sales of artificial intelligence technology. Founded in 2015, the company focuses on creating a patent examination platform that leverages AI to evaluate patentability and conduct comprehensive patent searches. This platform aids clients in their research and development efforts by enabling detailed analyses of all patent documents within its database. In addition to its core offerings, AI Samurai also supports patent research and technical investigations, positioning itself as a valuable resource in the field of intellectual property.
NanoMist Technologies engages with R&D, design, and sells machines in the areas such as alcoholic beverages and food enrichment, fragrance extraction, chemical purification process, wastewater management, and deodorization process. NanoMist Technologies manufactures and sells machines such as ultrasonic atomization machine, deodorization machine, hot spring water concentration machine, solvent recovery machine, VOCs recovery machine, and granular material production machine.
C4U Co., Ltd. is a Japanese company founded in 2018, specializing in the research and development of genome editing technologies aimed at addressing various intractable diseases. The company utilizes advanced methods such as CRISPR and Cas3 to create a platform that supports drug discovery and facilitates the development of new gene therapies. Beyond the medical field, C4U's innovative technologies are applicable across multiple industries, including agriculture, forestry, livestock, and fisheries, thereby contributing to solutions for a range of social issues. Based in Suita, Japan, C4U is committed to advancing scientific knowledge and practical applications through its cutting-edge genome editing capabilities.
Remohab Corporation designs remote telemedicine for patients with rehabilitation. The company was founded in 2017 and is based in Suita City, Japan.
MediTact is Contribute to the medical society through the challenging development of medical technologies that meet patient treatment needs.
ThinkCyte, Inc. develops an artificial intelligence-enabled, image-free visual cell sorting system that sort cells by morphology. It develops and sells equipment (cell separator) that uses cell sorting technology that continuously analyzes and separates cells by automatic control. It integrates optics, genomics, and information science to develop such machines. The company develops an image-based cell sorter using novel optics and machine learning methods. The company was founded in 2016 and is based in Tokyo, Japan with an additional office in San Carlos, California.
Chromocenter Inc. is a biopharmaceutical company based in Yonago, Japan, founded in 2005. The company specializes in the development of artificial chromosome technologies, which are utilized primarily for life sciences applications. By employing artificial chromosome vectors, Chromocenter focuses on advancing drug discovery processes, particularly in the field of medical pharmaceuticals. Its innovative approach aims to enhance the efficacy and efficiency of biopharmaceutical manufacturing, positioning the company at the forefront of next-generation therapeutic development.
Chromocenter Inc. is a biopharmaceutical company based in Yonago, Japan, founded in 2005. The company specializes in the development of artificial chromosome technologies, which are utilized primarily for life sciences applications. By employing artificial chromosome vectors, Chromocenter focuses on advancing drug discovery processes, particularly in the field of medical pharmaceuticals. Its innovative approach aims to enhance the efficacy and efficiency of biopharmaceutical manufacturing, positioning the company at the forefront of next-generation therapeutic development.
Jeplan, Inc. is a Tokyo-based company founded in January 2007 that specializes in recycling technologies and systems. The company develops innovative methods for recycling various materials, focusing on the conversion of textile products and plastic waste into energy and recycled oil. Jeplan employs proprietary chemical recycling technology to produce recycled polyethylene terephthalate (r-PET) and Bis(2-Hydroxyethyl) terephthalate (r-BHET) from waste food packaging, plastic PET bottles, and polyester fibers. These materials are subsequently used in the manufacture of r-PET products such as PET bottles and textiles. In addition to its recycling initiatives, Jeplan promotes the recycling of used uniforms and provides consulting services to businesses exploring uniform recycling options.
GlyTech, Inc. specializes in the manufacture of human type N-glycans and glycosylation technologies, as well as glycopeptide and glycoprotein synthesis. Established in 2012 and based in Kyoto, Japan, the company is dedicated to advancing the production of glycans and chemical glycosylation technologies for the development of innovative biopharmaceuticals and oligonucleotide therapeutics. GlyTech licenses glycosylated peptides and proteins and provides a range of services, including contract research and development, custom synthesis, and contract manufacturing. Additionally, the company engages in research collaborations and supplies standard reagents to support its partners in the pharmaceutical industry.
Immunosens Co. Ltd. is a Japanese company founded in 2018 that specializes in the research, development, manufacturing, and sale of bioanalytical instruments. The company focuses on creating electrochemical measurement devices designed to evaluate biomarkers, including genes, proteins, and cell signals through electrode reactions. By utilizing disposable printable electrodes in its sensors, Immunosens provides healthcare professionals with precise analysis and measurements, which are crucial for accurate diagnosis and food safety inspections. In addition to its product offerings, the company also provides healthcare consulting services, further supporting its commitment to enhancing diagnostic capabilities and safety in health-related fields.
Luxna Biotech Co., Ltd. is a Japanese company focused on the development of nucleic acid drugs, utilizing advanced technology to enhance the practical application of these therapies. Founded in 2017 and based in Suita, Japan, the company provides drug discovery support through artificial nucleic acid technology. Luxna Biotech aims to contribute to medical treatment, addressing the needs of patients with various health conditions.
Pi-Crystal Incorporation specializes in the development of printable organic semiconductor integrated circuits. The company offers a range of services including research and development, design, manufacturing, and sales of organic semiconductor materials and devices. Additionally, it provides consulting services related to organic semiconductor technology, leveraging its expertise in high-performance printable organic semiconductors. Established in 2013, Pi-Crystal is headquartered in Osaka, Japan, and operates as a subsidiary of Daicel Corporation as of January 2020.
Periotherapia is a Drug discovery business with triple negative breast cancer as the first indication. Periotherapia aims to selectively inhibit only ASV that is involved in pathogenesis without inhibiting physiological ASV in chronic diseases such as cancer, heart failure, arteriosclerosis, renal failure, and diabetic retinopathy. is.
Elves Ups is a collaborative AI dialogue system development tool
PGV Co., Ltd. is a Japanese company founded in September 2016 that focuses on the electroencephalograph (EEG) sector. The company aims to empower individuals to engage in self-care by enabling them to measure and understand their brain waves throughout their life cycle. PGV develops devices that utilize EEG technology and artificial intelligence to analyze brain activity, promoting a greater understanding of mental health and well-being. By providing tools for personal brain wave monitoring, PGV seeks to enhance individual self-awareness and foster proactive approaches to mental health management.
Remohab Corporation designs remote telemedicine for patients with rehabilitation. The company was founded in 2017 and is based in Suita City, Japan.
KOTAI Biotechnologies is a biotechnology company based in Osaka, Japan, that specializes in developing a structural modeling and analysis platform for immune cell sequence and data analysis. The company’s innovative technology enables the detailed examination of immune cell receptors from routine blood samples, providing insights into their structure and function. This capability has significant implications for understanding resistance to infections, autoimmune diseases, and cancer, making KOTAI Biotechnologies a key player in advancing immune-related health research and therapies.
KYSHOW Corporation, founded in 1994 and based in Osaka, Japan, operates seafood retail stores that specialize in high-quality fresh fish. The company focuses on domestically produced live natural fish sourced from Japan's coastal waters, ensuring freshness and quality for its customers. In addition to retailing fresh fish, KYSHOW also manufactures and distributes seasonal gifts, particularly midyear and year-end offerings, in collaboration with renowned department stores. This dual approach enables consumers to access fresh seafood while providing options for gift-giving, catering to both everyday and special occasion needs.
Bioworks Corporation, established in 2015 and headquartered in Tokyo, Japan, specializes in the modification and sale of polylactic acid and its derivatives. The company focuses on enhancing the properties of polylactic acid to create modified compounds that meet various industrial needs. As of December 2018, Bioworks operates as a subsidiary of TBM Co., Ltd. Through its innovative approaches in bioplastics, Bioworks aims to contribute to sustainable material solutions in the production industry.
KOTAI Biotechnologies is a biotechnology company based in Osaka, Japan, that specializes in developing a structural modeling and analysis platform for immune cell sequence and data analysis. The company’s innovative technology enables the detailed examination of immune cell receptors from routine blood samples, providing insights into their structure and function. This capability has significant implications for understanding resistance to infections, autoimmune diseases, and cancer, making KOTAI Biotechnologies a key player in advancing immune-related health research and therapies.
PGV Co., Ltd. is a Japanese company founded in September 2016 that focuses on the electroencephalograph (EEG) sector. The company aims to empower individuals to engage in self-care by enabling them to measure and understand their brain waves throughout their life cycle. PGV develops devices that utilize EEG technology and artificial intelligence to analyze brain activity, promoting a greater understanding of mental health and well-being. By providing tools for personal brain wave monitoring, PGV seeks to enhance individual self-awareness and foster proactive approaches to mental health management.
KOTAI Biotechnologies is a biotechnology company based in Osaka, Japan, that specializes in developing a structural modeling and analysis platform for immune cell sequence and data analysis. The company’s innovative technology enables the detailed examination of immune cell receptors from routine blood samples, providing insights into their structure and function. This capability has significant implications for understanding resistance to infections, autoimmune diseases, and cancer, making KOTAI Biotechnologies a key player in advancing immune-related health research and therapies.
Chromocenter Inc. is a biopharmaceutical company based in Yonago, Japan, founded in 2005. The company specializes in the development of artificial chromosome technologies, which are utilized primarily for life sciences applications. By employing artificial chromosome vectors, Chromocenter focuses on advancing drug discovery processes, particularly in the field of medical pharmaceuticals. Its innovative approach aims to enhance the efficacy and efficiency of biopharmaceutical manufacturing, positioning the company at the forefront of next-generation therapeutic development.
Nanophoton Corporation specializes in the research, development, manufacture, and sale of advanced laser microscopy products. The company offers a range of instruments, including laser Raman microscopes, wide field Raman scopes, and tip-enhanced Raman microscopes. Additionally, it provides specialized equipment such as closed vessels for Raman spectroscopy of lithium-ion batteries, Z polarizers for three-dimensional measurements, and laser speckle reducers for enhanced microscope illumination. These products serve various industries, including semiconductors, secondary batteries, carbon materials, inorganic compounds, polymers, pharmaceuticals, and food applications. Nanophoton distributes its products globally through a network of representatives and distributors. Founded in 2003, the company is headquartered in Osaka, Japan.
Kyoto Drug Discovery and Development Co. Ltd., based in Kyoto, Japan, specializes in the development of therapeutic drugs aimed at treating chronic degenerative eye diseases. The company focuses on innovative agents for conditions such as glaucoma, central retinal artery occlusion (CRAO), retinitis pigmentosa, and age-related macular degeneration (AMD), which are often considered incurable or intractable. By creating effective treatments for these serious conditions, Kyoto Drug Discovery and Development enables healthcare professionals to better diagnose and manage patients suffering from these debilitating eye diseases.
AFI Japan is a manufacturer based in Osaka that specializes in cell measuring equipment and inspection technologies. The company develops and sells products aimed at the food and life sciences industries, including electric filter separation technology and rapid detection systems for monitoring microbial contamination risks. By providing these advanced technologies, AFI Japan enables its clients to enhance food safety and respond effectively to various microbiological testing needs.
FunPep Company Limited is a biotechnology firm based in Tokyo, Japan, specializing in the research and development of pharmaceuticals, cosmetics, and medical devices utilizing functional peptides. Founded in 2013, the company is currently advancing several peptide-based treatments, including SR-0379, aimed at addressing intractable skin ulcers, and FPP003, which is undergoing Phase I/IIa clinical trials for psoriasis in Australia, alongside preclinical studies for ankylosing spondylitis in Japan. Additionally, FunPep is developing FPP004, an antibody-inducing peptide targeted at pollinosis. The company's innovative approach emphasizes the therapeutic potential of peptides across various health-related applications.
Matrixome Inc. is a Japanese company based in Osaka that specializes in the research, development, and supply of protein-based pharmaceutical preparations. Founded in 2015, the company focuses on products that facilitate cellular interactions with the extracellular environment. Its notable offerings include iMAtrix-221, which supports the purification and maintenance of cardiomyocytes; iMatrix-441, designed to induce endothelial progenitor cells for induced pluripotent stem (iPS) cell generation; and iMatrix-511, a recombinant human laminin-511 E8 fragment for use in cell culture. The company's work is grounded in the concept of "Matrixome," a term introduced by Professor Kiyotoshi Sekiguchi, which encapsulates the relationship between cells and their surroundings in living organisms.
JTEC Corporation designs, manufactures, and sells X-ray mirrors for synchrotron facilities in Japan. Its X-ray mirrors are used for study in the pharmaceutical, electronic, material, food, beauty, and other fields. The company also designs, develops, manufactures, and sells automated cell culture systems, as well as automated systems in various fields. JTEC Corporation was founded in 1993 and is headquartered in Ibaraki, Japan.
Microwave Chemical Co.,Ltd. produces and sells sustainable type chemical products and fuels such as various fatty acid ester and biodiesel, that are manufactured from recyclable resources including the plant origin raw material and waste. The company was founded in 2007 and is based in Osaka, Japan.